Work

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

Year: 1998

Type: article

Source: PubMed

Authors: G L Denardo, S J Denardo, D L Kukis, R T O'Donnell, S Shen, D S Goldstein, L A Kroger, Q Salako, D A Denardo, G R Mirick, L F Mausner, S C Srivastava, C F Meares

Institutions: University of California Davis Medical Center, University of California, Davis, Brookhaven National Laboratory

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Translational Multimodality " Antibody" Therapy

OpenAlex ID: W2414631060

FWCI: 7.3

Cites:

Cited by: 60

Related to: 10